• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

A year after a death and accompanying trial hold, Poseida hopes for reprieve with early...

cafead

Administrator
Staff member
  • cafead   Aug 31, 2021 at 11:32: AM
via The death of a patient in a solid tumor trial hit Poseida hard last August, but since then the hold has been lifted and the biotech is now reporting some early and broadly positive data

article source
 

<